Skip to main content
. 2017 May 11;12(5):e0175476. doi: 10.1371/journal.pone.0175476

Fig 4. Cumulative rates of patients remaining free of VAP in the AG group and control group, using the Kaplan-Meier method.

Fig 4

VAP, Ventilator-Associated Pneumonia; AG, Anapnoguard.